AZD0424 is an orally active, and dual selective Src/Abl kinase inhibitor with potential antineoplastic activity[1]. AZD0424 induces apoptosis and cell cycle arrest in lymphoma cells[2].
Molecular Weight:
528.99
CAS Number:
[692054-06-1]
Formula:
C25H29ClN6O5
Target:
Apoptosis,Bcr-Abl,Src
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
